Literature DB >> 28658632

Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.

Farshad Farshidfar, Siyuan Zheng, Marie-Claude Gingras, Yulia Newton, Juliann Shih, A Gordon Robertson, Toshinori Hinoue, Katherine A Hoadley, Ewan A Gibb, Jason Roszik, Kyle R Covington, Chia-Chin Wu, Eve Shinbrot, Nicolas Stransky, Apurva Hegde, Ju Dong Yang, Ed Reznik, Sara Sadeghi, Chandra Sekhar Pedamallu, Akinyemi I Ojesina, Julian M Hess, J Todd Auman, Suhn K Rhie, Reanne Bowlby, Mitesh J Borad, Andrew X Zhu, Josh M Stuart, Chris Sander, Rehan Akbani, Andrew D Cherniack, Vikram Deshpande, Taofic Mounajjed, Wai Chin Foo, Michael S Torbenson, David E Kleiner, Peter W Laird, David A Wheeler, Autumn J McRee, Oliver F Bathe, Jesper B Andersen, Nabeel Bardeesy, Lewis R Roberts, Lawrence N Kwong.   

Abstract

Entities:  

Year:  2017        PMID： 28658632      PMCID： PMC6141445          DOI： 10.1016/j.celrep.2017.06.008

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


× No keyword cloud information.
  52 in total

1.  Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma.

Authors:  Yasuhito Arai; Yasushi Totoki; Fumie Hosoda; Tomoki Shirota; Natsuko Hama; Hiromi Nakamura; Hidenori Ojima; Koh Furuta; Kazuaki Shimada; Takuji Okusaka; Tomoo Kosuge; Tatsuhiro Shibata
Journal:  Hepatology       Date:  2014-02-18       Impact factor: 17.425

2.  New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing.

Authors:  Jeffrey S Ross; Kai Wang; Laurie Gay; Rami Al-Rohil; Janne V Rand; David M Jones; Hwa J Lee; Christine E Sheehan; Geoff A Otto; Gary Palmer; Roman Yelensky; Doron Lipson; Deborah Morosini; Matthew Hawryluk; Daniel V T Catenacci; Vincent A Miller; Chaitanya Churi; Siraj Ali; Philip J Stephens
Journal:  Oncologist       Date:  2014-02-21

3.  Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma.

Authors:  Hyun Goo Woo; Jeong-Hoon Lee; Jung-Hwan Yoon; Chung Yong Kim; Hyo-Suk Lee; Ja June Jang; Nam-Joon Yi; Kyung-Suk Suh; Kuhn Uk Lee; Eun Sung Park; Snorri S Thorgeirsson; Yoon Jun Kim
Journal:  Cancer Res       Date:  2010-04-15       Impact factor: 12.701

Review 4.  Difficult Diagnostic Problems in Pancreatobiliary Neoplasia.

Authors:  Jacob R Bledsoe; Shweta A Shinagare; Vikram Deshpande
Journal:  Arch Pathol Lab Med       Date:  2015-07       Impact factor: 5.534

5.  2-Hydroxyglutarate Inhibits ATP Synthase and mTOR Signaling.

Authors:  Xudong Fu; Randall M Chin; Laurent Vergnes; Heejun Hwang; Gang Deng; Yanpeng Xing; Melody Y Pai; Sichen Li; Lisa Ta; Farbod Fazlollahi; Chuo Chen; Robert M Prins; Michael A Teitell; David A Nathanson; Albert Lai; Kym F Faull; Meisheng Jiang; Steven G Clarke; Timothy F Cloughesy; Thomas G Graeber; Daniel Braas; Heather R Christofk; Michael E Jung; Karen Reue; Jing Huang
Journal:  Cell Metab       Date:  2015-07-16       Impact factor: 27.287

Review 6.  Functional and genetic deconstruction of the cellular origin in liver cancer.

Authors:  Jens U Marquardt; Jesper B Andersen; Snorri S Thorgeirsson
Journal:  Nat Rev Cancer       Date:  2015-11       Impact factor: 60.716

7.  SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2.

Authors:  Kimberly H Kim; Woojin Kim; Thomas P Howard; Francisca Vazquez; Aviad Tsherniak; Jennifer N Wu; Weishan Wang; Jeffrey R Haswell; Loren D Walensky; William C Hahn; Stuart H Orkin; Charles W M Roberts
Journal:  Nat Med       Date:  2015-11-09       Impact factor: 53.440

8.  Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas.

Authors:  P Wang; Q Dong; C Zhang; P-F Kuan; Y Liu; W R Jeck; J B Andersen; W Jiang; G L Savich; T-X Tan; J T Auman; J M Hoskins; A D Misher; C D Moser; S M Yourstone; J W Kim; K Cibulskis; G Getz; H V Hunt; S S Thorgeirsson; L R Roberts; D Ye; K-L Guan; Y Xiong; L-X Qin; D Y Chiang
Journal:  Oncogene       Date:  2012-07-23       Impact factor: 8.756

Review 9.  Metabolic consequences of oncogenic IDH mutations.

Authors:  Seth J Parker; Christian M Metallo
Journal:  Pharmacol Ther       Date:  2015-05-05       Impact factor: 13.400

Review 10.  What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer.

Authors:  Julie-Aurore Losman; William G Kaelin
Journal:  Genes Dev       Date:  2013-04-15       Impact factor: 12.890
View more
  54 in total

1.  Hybrid Capture-Based Tumor Sequencing and Copy Number Analysis to Confirm Origin of Metachronous Metastases in BRCA1-Mutant Cholangiocarcinoma Harboring a Novel YWHAZ-BRAF Fusion.

Authors:  Huat C Lim; Meagan Montesion; Thomas Botton; Eric A Collisson; Sarah E Umetsu; Spencer C Behr; John D Gordan; Phil J Stephens; Robin K Kelley
Journal:  Oncologist       Date:  2018-04-05

2.  TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic Cholangiocarcinoma.

Authors:  Lipika Goyal; Lei Shi; Leah Y Liu; Ferran Fece de la Cruz; Jochen K Lennerz; Srivatsan Raghavan; Ignaty Leschiner; Liudmila Elagina; Giulia Siravegna; Raymond W S Ng; Phuong Vu; Krushna C Patra; Supriya K Saha; Raul N Uppot; Ron Arellano; Stephanie Reyes; Takeshi Sagara; Sachie Otsuki; Brandon Nadres; Heather A Shahzade; Ipsita Dey-Guha; Isobel J Fetter; Islam Baiev; Emily E Van Seventer; Janet E Murphy; Cristina R Ferrone; Kenneth K Tanabe; Vikram Deshpande; James J Harding; Rona Yaeger; Robin K Kelley; Alberto Bardelli; A John Iafrate; William C Hahn; Cyril H Benes; David T Ting; Hiroshi Hirai; Gad Getz; Dejan Juric; Andrew X Zhu; Ryan B Corcoran; Nabeel Bardeesy
Journal:  Cancer Discov       Date:  2019-05-20       Impact factor: 39.397

3.  Distinct histomorphological features are associated with IDH1 mutation in intrahepatic cholangiocarcinoma.

Authors:  Tao Wang; Esther Drill; Efsevia Vakiani; Linda Ma Pak; Thomas Boerner; Gokce Askan; Juan Manuel Schvartzman; Amber L Simpson; William R Jarnagin; Carlie S Sigel
Journal:  Hum Pathol       Date:  2019-05-21       Impact factor: 3.466

Review 4.  Molecular Pathogenesis of Low-Grade Glioma.

Authors:  Devin Bready; Dimitris G Placantonakis
Journal:  Neurosurg Clin N Am       Date:  2019-01       Impact factor: 2.509

Review 5.  [Biliary tract cancers : Molecular characterization and identification of novel prognostic markers].

Authors:  B Goeppert
Journal:  Pathologe       Date:  2017-11       Impact factor: 1.011

6.  The Limitations of Standard Clinicopathologic Features to Accurately Risk-Stratify Prognosis after Resection of Intrahepatic Cholangiocarcinoma.

Authors:  Fabio Bagante; Katiuscha Merath; Malcolm H Squires; Matthew Weiss; Sorin Alexandrescu; Hugo P Marques; Luca Aldrighetti; Shishir K Maithel; Carlo Pulitano; Todd W Bauer; Feng Shen; George A Poultsides; Olivier Soubrane; Guillaume Martel; B Groot Koerkamp; Alfredo Guglielmi; Endo Itaru; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2018-01-19       Impact factor: 3.452

7.  Mitochondrial metabolism supports resistance to IDH mutant inhibitors in acute myeloid leukemia.

Authors:  Lucille Stuani; Marie Sabatier; Estelle Saland; Guillaume Cognet; Nathalie Poupin; Claudie Bosc; Florence A Castelli; Lara Gales; Evgenia Turtoi; Camille Montersino; Thomas Farge; Emeline Boet; Nicolas Broin; Clément Larrue; Natalia Baran; Madi Y Cissé; Marc Conti; Sylvain Loric; Tony Kaoma; Alexis Hucteau; Aliki Zavoriti; Ambrine Sahal; Pierre-Luc Mouchel; Mathilde Gotanègre; Cédric Cassan; Laurent Fernando; Feng Wang; Mohsen Hosseini; Emeline Chu-Van; Laurent Le Cam; Martin Carroll; Mary A Selak; Norbert Vey; Rémy Castellano; François Fenaille; Andrei Turtoi; Guillaume Cazals; Pierre Bories; Yves Gibon; Brandon Nicolay; Sébastien Ronseaux; Joseph R Marszalek; Koichi Takahashi; Courtney D DiNardo; Marina Konopleva; Véra Pancaldi; Yves Collette; Floriant Bellvert; Fabien Jourdan; Laetitia K Linares; Christian Récher; Jean-Charles Portais; Jean-Emmanuel Sarry
Journal:  J Exp Med       Date:  2021-05-03       Impact factor: 14.307

8.  YAP Tyrosine Phosphorylation and Nuclear Localization in Cholangiocarcinoma Cells Are Regulated by LCK and Independent of LATS Activity.

Authors:  Takaaki Sugihara; Nathan W Werneburg; Matthew C Hernandez; Lin Yang; Ayano Kabashima; Petra Hirsova; Lavanya Yohanathan; Carlos Sosa; Mark J Truty; George Vasmatzis; Gregory J Gores; Rory L Smoot
Journal:  Mol Cancer Res       Date:  2018-06-14       Impact factor: 5.852

9.  Genomic profiling of multifocal intrahepatic cholangiocarcinoma reveals intraindividual concordance of genetic alterations.

Authors:  Sung Hwan Lee; Eve B Simoneau; Tatiana Karpinets; P Andrew Futreal; Jianjun Zhang; Milind Javle; Jianhua Zhang; Jean-Nicolas Vauthey; Ju-Seog Lee; Jeannelyn S Estrella; Yun Shin Chun
Journal:  Carcinogenesis       Date:  2021-04-17       Impact factor: 4.944

10.  Hippo Cascade Controls Lineage Commitment of Liver Tumors in Mice and Humans.

Authors:  Shanshan Zhang; Jingxiao Wang; Haichuan Wang; Lingling Fan; Biao Fan; Billy Zeng; Junyan Tao; Xiaolei Li; Li Che; Antonio Cigliano; Silvia Ribback; Frank Dombrowski; Bin Chen; Wenming Cong; Lixin Wei; Diego F Calvisi; Xin Chen
Journal:  Am J Pathol       Date:  2018-01-31       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.